Standard Chemical & Pharmaceutical Co (TPE:1720) Cash Flow for Dividends: NT$0 Mil (TTM As of Dec. 2025)


TPE:1720 Standard Chemical & Pharmaceutical Co Ltd TPE:1720
95 GF Score
Price NT$63.90
GF Value NT$70.94
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Standard Chemical & Pharmaceutical Co Cash Flow for Dividends?

Standard Chemical & Pharmaceutical Co TPE:1720 95 Cash Flow for Dividends is NT$0 Mil as of Dec. 2025. GuruFocus rates TPE:1720 with a GF Score™ of 95/100 and a GF Value™ of NT$70.94 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Standard Chemical & Pharmaceutical Co's cash flow for dividends for the three months ended in Dec. 2025 was NT$0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Standard Chemical & Pharmaceutical Co's annual payment of dividends increased from Dec. 2023 (NT$-447 Mil) to Dec. 2024 (NT$-482 Mil) and increased from Dec. 2024 (NT$-482 Mil) to Dec. 2025 (NT$-500 Mil).

Standard Chemical & Pharmaceutical Co Cash Flow for Dividends Related Terms

Standard Chemical & Pharmaceutical Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Standard Chemical & Pharmaceutical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Standard Chemical & Pharmaceutical Co Cash Flow for Dividends Chart

Standard Chemical & Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -321.65 -446.74 -446.74 -482.48 -500.35

Standard Chemical & Pharmaceutical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TPE:1720
95GF Score
Standard Chemical & Pharmaceutical Co Ltd TPE:1720
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Standard Chemical & Pharmaceutical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of NT$0 Mil mean?
Standard Chemical & Pharmaceutical Co (TPE:1720) has a Cash Flow for Dividends of NT$0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Standard Chemical & Pharmaceutical Co and its competitors.
Is Standard Chemical & Pharmaceutical Co's Cash Flow for Dividends too high?
Standard Chemical & Pharmaceutical Co's current Cash Flow for Dividends is NT$0 Mil. Overall, Standard Chemical & Pharmaceutical Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Standard Chemical & Pharmaceutical Co's Cash Flow for Dividends compare to ZTS and UTHR?
Standard Chemical & Pharmaceutical Co's Cash Flow for Dividends of NT$0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Standard Chemical & Pharmaceutical Co and its competitors. Standard Chemical & Pharmaceutical Co's current Cash Flow for Dividends is NT$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard Chemical & Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co (TPE:1720) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$70.94, compared to a current price of NT$63.90 — trading 9.9% below its estimated fair value. The current Cash Flow for Dividends is NT$0 Mil. Standard Chemical & Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Standard Chemical & Pharmaceutical Co (TPE:1720), the current Cash Flow for Dividends is NT$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Standard Chemical & Pharmaceutical Co (TPE:1720) Overvalued in 2026?

Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$63.90 is trading 9.9% below its estimated GF Value™ of NT$70.94. GuruFocus considers Standard Chemical & Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TPE:1720:

  • Cash Flow for Dividends: NT$0 Mil
  • GF Value™: NT$70.94 vs. price of NT$63.90 (9.9% below fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the TPE:1720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Standard Chemical & Pharmaceutical Co Business Description

Address No.6-20,Tuku, Sinying District, Tuku Village, Tainan, TWN, 73055
Standard Chemical & Pharmaceutical Co Ltd is engaged in the manufacturing and sales of Chinese and western medicine, cosmetics, beverage, normal instruments and medical instruments. Its segments include Medicine, Dietary supplement and Ingredients. The majority of the revenue is derived from the Medicine segment. Geographically it operates in Taiwan, Japan and Others with Taiwan generating the maximum revenue.
95GF Score

Get the complete analysis for TPE:1720

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$63.90
Price
NT$70.94
GF Value